云涛生物 (831591.OC)

+ 收藏

现金流量表(云涛生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 86,064,660.82138,490,906.5764,462,125.07135,315,902.7376,798,021.55
 收到的税费返还(元) 531.971,920,555.38187,629.145,127,342.815,284,881.67
 收到其他与经营活动有关的现金(元) 1,483,548.301,659,781.061,276,147.273,182,952.431,340,344.91
 经营活动现金流入小计(元) 87,548,741.09142,071,243.0165,925,901.48143,626,197.9783,423,248.13
 购买商品、接受劳务支付的现金(元) 53,759,439.5355,129,075.8234,457,913.0898,092,213.6368,359,533.15
 支付给职工以及为职工支付的现金(元) 20,461,163.4129,700,858.7114,208,566.1728,671,559.3616,067,608.04
 支付的各项税费(元) 7,689,390.4710,821,333.265,437,902.085,629,009.712,132,367.71
 支付其他与经营活动有关的现金(元) 1,608,244.766,680,732.98771,416.655,456,347.071,379,424.09
 经营活动现金流出小计(元) 83,518,238.17102,332,000.7754,875,797.98137,849,129.7787,938,932.99
 经营活动产生的现金流量净额(元) 4,030,502.9239,739,242.2411,050,103.505,777,068.20-4,515,684.86
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -376,492.00---
 投资活动现金流入小计(元) -376,492.00---
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,850,935.008,263,218.672,360,534.801,150,995.891,944,200.85
 投资活动现金流出小计(元) 1,850,935.008,263,218.672,360,534.801,150,995.891,944,200.85
 投资活动产生的现金流量净额(元) -1,850,935.00-7,886,726.67-2,360,534.80-1,150,995.89-1,944,200.85
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 35,000,000.0074,000,000.0064,000,000.00158,000,000.00158,000,000.00
 筹资活动现金流入小计(元) 35,000,000.0074,000,000.0064,000,000.00158,000,000.00158,000,000.00
 偿还债务支付的现金(元) 30,000,000.0065,000,000.0050,000,000.00171,748,749.87164,438,649.57
 分配股利、利润或偿付利息支付的现金(元) 10,993,440.8421,343,407.4919,303,675.184,177,464.472,216,368.53
 支付其他与筹资活动有关的现金(元) ---1,577,329.00-
 筹资活动现金流出小计(元) 40,993,440.8486,343,407.4969,303,675.18177,503,543.34166,655,018.10
 筹资活动产生的现金流量净额(元) -5,993,440.84-12,343,407.49-5,303,675.18-19,503,543.34-8,655,018.10
四、汇率变动对现金及现金等价物的影响(元) 931,574.75106,635.9030,213.48541,559.38411,949.69
五、现金及现金等价物净增加额(元) -2,882,298.1719,615,743.983,416,107.00-14,335,911.65-14,702,954.12
 加:期初现金及现金等价物余额(元) 20,353,967.15738,223.17738,223.1715,074,134.8215,074,134.82
 期末现金及现金等价物余额(元) 17,471,668.9820,353,967.154,154,330.17738,223.17371,180.70
补充资料:
 净利润(元) 8,745,790.7220,947,027.099,184,359.251,448,903.901,506,080.07
 资产减值准备(元) -287,226.64285,162.14-2,064.502,549,475.68-2,230,584.06
 固定资产和投资性房地产折旧(元) 14,002,910.3527,400,990.1113,649,651.1725,774,633.8511,777,654.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 14,002,910.3527,400,990.1113,649,651.1725,774,633.8511,777,654.24
 无形资产摊销(元) 246,967.32493,934.64246,967.32499,834.47252,867.12
 长期待摊费用摊销(元) 113,193.08228,351.89124,489.46467,695.3137,582.62
 处置固定资产、无形资产和其他长期资产的损失(元) 3,106.19431,098.87409,046.36347,816.02-
 固定资产报废损失(元) 566,309.97255,137.91-205,638.30-
 财务费用(元) 1,973,586.313,536,466.041,584,222.413,681,182.761,926,269.00
 投资损失(元) -110,913.16---
 递延所得税(元) -3,421,056.69599,039.19-2,576,604.93-4,597,664.82-4,209,379.64
  其中:递延所得税资产减少(元) -2,942,678.705,337,672.15-1,415,922.26-7,566,514.06-3,264,466.72
 递延所得税负债增加(元) -478,377.99-4,738,632.96-1,160,682.672,968,849.24-944,912.92
 存货的减少(元) -445,628.5916,215,786.3811,486,242.309,841,632.6815,520,807.05
 经营性应收项目的减少(元) 10,918,486.79-59,226,151.63-8,936,777.80-381,418.89-4,329,083.08
 经营性应付项目的增加(元) -28,413,908.6627,810,080.46-14,149,611.01-36,703,788.67-25,529,284.54
 其他(元) --499,301.35-2,123,402.04-
 现金的期末余额(元) 17,471,668.9820,353,967.154,154,330.17738,223.17371,180.70
 减:现金的期初余额(元) 20,353,967.15738,223.17738,223.1715,074,134.8215,074,134.82
 现金及现金等价物的净增加额(元) -2,882,298.1719,615,743.983,416,107.00-14,335,911.65-14,702,954.12
公告日期 2024-08-292024-04-262023-08-292023-04-272022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院